Literature DB >> 2123642

Nutritional assessment of patients with extended left ventricular assist device support.

J D Vega1, S M Poindexter, B Radovancevic, C M Burnett, J L Lonquist, S Birovljev, J M Duncan, O H Frazier.   

Abstract

The nutritional status of nine patients with end-stage heart disease who were supported by a left ventricular assist device (LVAD) for more than 30 days while awaiting cardiac transplantation was evaluated. Nutritional status was indicated by the following scale: 0-2, adequate nourishment; 3-5, moderate malnourishment; greater than 5, severe malnourishment. This scale was based on serial assessments of albumin, transferrin, total lymphocyte count, percentage of ideal body weight, midarm circumference, triceps skinfold, and arm muscle circumference. Each variable was compared with established standards before implantation and before transplantation times and assessed 1 point if less than the normal value and 0 points if within the normal range. At the time of LVAD implantation, 5 patients had a score of 0-2, 3 patients had a score of 3-5, and 1 patient had a score greater than 5. At the time of cardiac transplantation, 7 patients had a score of 0-2, 2 patients had a score of 3-5, and no patients had a score greater than 5. The patients who were able to meet at least 50% of their daily caloric and protein requirements by oral intake alone were noted. At LVAD implantation, only 2 patients (22%) met this requirement; however, 6 patients (67%) met this requirement at the time of cardiac transplantation. All 9 patients underwent cardiac transplantation, and 8 survived. Thus, it appears that extended LVAD support and maintenance of hemodynamic stability allow patients to regain the desire and ability to achieve adequate nutritional status, which may considerably reduce their perioperative transplant risks.

Entities:  

Mesh:

Year:  1990        PMID: 2123642

Source DB:  PubMed          Journal:  ASAIO Trans        ISSN: 0889-7190


  1 in total

1.  Readmission due to driveline infection can be predicted by new score by using serum albumin and body mass index during long-term left ventricular assist device support.

Authors:  Teruhiko Imamura; Koichiro Kinugawa; Daisuke Nitta; Toshiro Inaba; Hisataka Maki; Masaru Hatano; Osamu Kinoshita; Kan Nawata; Shunei Kyo; Minoru Ono
Journal:  J Artif Organs       Date:  2015-01-21       Impact factor: 1.731

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.